In this study, we wondered whether SPARC might act as a DAMP-promoting inflammasome activation in the in vitro steatosis assay and in high-fat diet-induced NAFLD mice. The gene discussed is SPARC; the disease is metabolic dysfunction-associated steatotic liver disease.